Literature DB >> 11160789

Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus.

C Boshoff1, Y Chang.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is a newly identified gammaherpesvirus associated with all clinical forms of Kaposi's sarcoma (KS), body-cavity-based, primary effusion lymphomas (PELs), and a subset of Castleman's disease (CD). Sequence analysis of the KSHV genome demonstrates an extensive array of genes with homology to cellular genes involved in cell cycle regulation, cell proliferation, apoptosis, and immune modulation. Functional studies indicate that these genes may modify the host cell environment, contributing to the pathogenesis of KSHV-associated disorders. Several KSHV genes have been found to cause dysregulated cell proliferation or to interfere with established tumor suppressor pathways. The epidemiologic association of KSHV with malignancies and the coding features of its genome suggest that it is a new DNA tumor virus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160789     DOI: 10.1146/annurev.med.52.1.453

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  49 in total

1.  Gammaherpesvirus lytic gene expression as characterized by DNA array.

Authors:  Joo Wook Ahn; Kenneth L Powell; Paul Kellam; Dagmar G Alber
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Preparation and characterization of polyclonal antibody against Kaposi's sarcoma-associated herpesvirus lytic gene encoding RTA.

Authors:  Weifei Fan; Qiao Tang; Chenyou Shen; Di Qin; Chun Lu; Qin Yan
Journal:  Folia Microbiol (Praha)       Date:  2015-04-02       Impact factor: 2.099

3.  KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice.

Authors:  Christopher H Parsons; Laura A Adang; Jon Overdevest; Christine M O'Connor; J Robert Taylor; David Camerini; Dean H Kedes
Journal:  J Clin Invest       Date:  2006-06-22       Impact factor: 14.808

Review 4.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

5.  K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function.

Authors:  Tyson V Sharp; Hsei-Wei Wang; Andrew Koumi; Daniel Hollyman; Yoshio Endo; Hongtao Ye; Ming-Qing Du; Chris Boshoff
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.

Authors:  Ryota Nakayama; Yumiko Ueno; Keiji Ueda; Tomoyuki Honda
Journal:  Oncogene       Date:  2019-02-15       Impact factor: 9.867

7.  Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter.

Authors:  Michael Pearce; Satoko Matsumura; Angus C Wilson
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells.

Authors:  Jisu Lee; Hyungtaek Jeon; Seung-Min Yoo; Jinsung Park; Myung-Shin Lee
Journal:  Tumour Biol       Date:  2015-09-21

9.  IL-10 promoter transactivation by the viral K-RTA protein involves the host-cell transcription factors, specificity proteins 1 and 3.

Authors:  Masanori Miyazawa; Kohji Noguchi; Mana Kujirai; Kazuhiro Katayama; Satoshi Yamagoe; Yoshikazu Sugimoto
Journal:  J Biol Chem       Date:  2017-11-28       Impact factor: 5.157

10.  Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects.

Authors:  C Liu; Y Okruzhnov; H Li; J Nicholas
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.